Mouse IgG

Mouse IgG 제품 목록

  • 속성

    Beads (1)Antibody (1)

  • 제품 라이브러리

    온라인 (2)

  • Rabbit (2)

  • 태그

    - (2)

  • 마커

    - (1)Acridinium ester Labeled (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
AMG-S163
Rabbit
HEK293
Anti-Mouse IgG-Acridinium ester (MALS verified)
MPC-A003
Rabbit
-
Anti-Mouse IgG-coupled Magnetic Beads (recommended for MPCLIA)
총 수량2
  • 1

Mouse IgG분자 배경

Chemiluminescence immunoassay (CLIA) is a much more effective measurement with the advantages of high sensitivity, uniformity and broad dynamic range. However, in traditional chemiluminescent immunoassay (CLIA),microplate was applied to immobilize antigen or antibody by physical absorption, which holds a negative effect on the perfor-mance of assay because of the low specific surface area of micro-plate. The use of micromagnetic particles (MMPs) have proven to be a support for addressing the shortage of traditional CLIA mentioned above The chemiluminescent immunoassay is a technique used for disease diagnosis, drug development, chemical reaction monitoring, and many other applications. The MMPs-based chemiluminescence immunoassays could improve the surface area for immobilization, capture efficiency and accuracy of the assay, thus obtaining higher sensitivity and shorter analysis time.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
BelapectinGR-MD-02Phase 3 ClinicalGalectin Therapeutics IncMetabolic Dysfunction-Associated Steatotic Liver Disease; Squamous Cell Carcinoma of Head and Neck; Fibrosis; Hypertension, Portal; Psoriasis; Hepatic Insufficiency; Esophageal and Gastric Varices; Melanoma; Carcinoma, Non-Small-Cell Lung
상세
OlitigaltinGB-0139; TD-139Phase 2 ClinicalThe University Of Edinburgh, Lund University FoundationIdiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19)
상세
Galactomannan CGM-CT-01Phase 2 ClinicalGalectin Therapeutics IncHead and Neck Neoplasms; Coronavirus Disease 2019 (COVID-19); Small Cell Lung Carcinoma; Breast Neoplasms; Prostatic Neoplasms; Coronaviridae Infections; Colorectal Neoplasms; Bile Duct Neoplasms; Lung Neoplasms; Gallbladder Neoplasms; Melanoma
상세
SelvigaltinGB-1211; GB1211Phase 2 ClinicalGalecto IncSquamous Cell Carcinoma of Head and Neck; Metabolic Dysfunction-Associated Steatotic Liver Disease; Hepatic Insufficiency; Melanoma; Carcinoma, Non-Small-Cell Lung
상세
ProLectin-MPhase 2 ClinicalBioXyTran IncCytokine Release Syndrome; Coronavirus Disease 2019 (COVID-19); Influenza, Human
상세
Gal-400Gal-400Phase 1 ClinicalGalecto IncMetabolic Dysfunction-Associated Steatotic Liver Disease; Liver Cirrhosis
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
OcriplasminA-01016; THR-409ApprovedThrombogenicsJetrea, JejetreaUnited StatesVitreomacular AdhesionThrombogenics Inc2012-10-17Vitreous Detachment; Arterial Occlusive Diseases; Disease Progression; Stroke; Retinal Diseases; Diabetic macular oedema; Uveitis; Vitreomacular Adhesion; Venous Thrombosis; Eye Diseases; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion
상세
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호